Contemporary surgical management of vulvar cancer is associated with improved survival but increased reoperation rate: A Finnish nationwide study.

Personalized surgery cohort demonstrated significantly improved 2-year OS (67.1% vs 77.4%; p = 0.003) and disease-specific survival (74.2% vs 82.6%; p = 0.009) compared to the radical surgery cohort.

Increased rates of postoperative complications (7.6% vs 20.3%; p < 0.001) and reoperations (5.6% vs 10.0%; p = 0.039) were observed in the personalized surgery cohort; treatment delays were not increased.